NCT04308187

Brief Summary

The Coronavirus has a major influence on stress for the general population. However, data are currently non-existent concerning the perception and knowledge of the epidemic, the feeling of information from companies / establishments / governments, the means of protection used, the feelings of fear generated and their impact on feelings of stigmatization towards certain ethnic groups or categories of patients (those who cough ...), or relationships with socio-demographic factors or lifestyle.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 12, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 13, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

March 13, 2020

Status Verified

March 1, 2020

Enrollment Period

2 years

First QC Date

March 12, 2020

Last Update Submit

March 12, 2020

Conditions

Stress, Psychological

Keywords

Stress, PsychologicalCoronavirusEpidemics

Outcome Measures

Primary Outcomes (1)

  • Stress

    Stress level will be assessed by questionnaire

    Day 1

Secondary Outcomes (5)

  • Perception and knowledge of the epidemic

    Day 1

  • Feeling of information on the part of companies / establishments / governments

    Day 1

  • Means of protection

    Day 1

  • Feelings of fear generated and its impact on feelings of stigmatization towards ethnic groups or categories of patients

    Day 1

  • Sociodemographic factors and lifestyle habits

    Day 1

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General population

You may qualify if:

  • Anyone volunteer to participate

You may not qualify if:

  • Anyone non-voluntary to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Clermont-Ferrand

Clermont-Ferrand, 63000, France

Location

MeSH Terms

Conditions

Stress, PsychologicalCoronavirus Infections

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Fréderic DUTHEIL

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lise Laclautre

CONTACT

0473754963promo_interne_drci@chu-clermontferrand.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2020

First Posted

March 13, 2020

Study Start

March 11, 2020

Primary Completion

March 1, 2022

Study Completion

March 1, 2022

Last Updated

March 13, 2020

Record last verified: 2020-03

Locations

FR(1)